跳至主要内容
临床试验/NCT03579381
NCT03579381已完成不适用

Specimen Repository for HIV Immunopathogenesis

AIDS Healthcare Foundation1 个研究点 分布在 1 个国家目标入组 9 人开始时间: 2017年7月31日最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
入组人数
9
试验地点
1
主要终点
HIV progression from acute infection to viral suppression

研究概览

简要总结

Specimen Repository for HIV Immunopathogenesis Studies

详细描述

The goal is to build a large specimen repository for collaborating scientists to run studies of immunity and HIV-1.

研究设计

研究类型
Observational
观察模型
Cohort
时间视角
Prospective

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • HIV positive (acutely infected, viremic and elite controllers)
  • Signed Informed Consent Form
  • Age at least 18 years old
  • Immune controllers, two types: "Elite suppressors" (HIV-positive with any three consecutive plasma HIV-1 RNA PCR undetectable while off treatment) or "viremic suppressors" (HIV-positive with any three consecutive HIV-1 RNA PCR <3000 while off treatment).
  • Acutely infected subjects:
  • Persons identified to have a negative HIV antibody response (ELISA) but positive detection of HIV-1 in the blood (RT-PCR) or individuals who have evidence of a recent (past 30 days) HIV negative result along with a current HIV positive result.

排除标准

  • Uncontrolled bleeding diathesis.
  • Inability to provide informed consent.

结局指标

主要结局

HIV progression from acute infection to viral suppression

时间窗: 2 years

Outcomes will depend on scientists who use the samples for further study

HIV progression and control by elite and viremic suppressors

时间窗: 2 years

Outcomes will depend on scientists who use the samples for study

次要结局

未报告次要终点

研究者

申办方类型
Other
责任方
Sponsor

研究点 (1)

Loading locations...

相似试验